45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
20,367
Insurances with rates
4
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 253122-5929975 | sipuleucel-T - Su | $164,834 | $98,900 | — | — | 8 |
| 253416-6867027 | Tremelimumab actl 300 mg/15 mL Inj | $122,244 | $73,346 | — | — | 8 |
| 253565-6933414 | Ocrelizumab-Hyaluronidase (920 mg-23,000 units/23 mL) Inj | $121,933 | $73,160 | — | — | 8 |
| 2745419-4840443 | VALVE SAPIEN 3 ULTRA THV 23MM W COMMAND | $121,875 | $73,125 | — | — | 8 |
| 2745420-4840444 | VALVE SAPIEN 3 ULTRA THV 26MM W COMMAND | $121,875 | $73,125 | — | — | 8 |
| 2745952-5008381 | VALVE SAPIEN 3 THV 29MM W COMMAND SYSTEM | $121,875 | $73,125 | — | — | 8 |
| 251739-5136405 | Ipilimumab 5 mg/ml Inj 40 ml | $106,987 | $64,192 | — | — | 8 |
| 2746267-5296404 | SENSOR CARDIOMEMS | $88,125 | $52,875 | — | — | 8 |
| 253467-6875792 | Ustekinumab 90 mg/mL Syringe | $86,055 | $51,633 | — | — | 8 |
| 253375-6699594 | Loncastuximab tesirine 10 mg Inj | $83,675 | $50,205 | — | — | 8 |
| 251681-6133547 | Pegaspargase 750 I-Units/ml Inj 5 ml | $79,227 | $47,536 | — | — | 8 |
| 2737657-3038906 | CATHETER IMPELLA 2.5 | $75,000 | $45,000 | — | — | 8 |
| 2737657-6950088 | SET PUMP IMPELLA 2.5 AIC | $75,000 | $45,000 | — | — | 8 |
| 2746234-5276902 | DEFIB INOGEN DF4 CRT-D G140 | $70,875 | $42,525 | — | — | 8 |
| 253268-6229567 | Ravulizumab cwvz 1100 mg/11 mL Inj | $70,772 | $42,463 | — | — | 8 |
| 253473-6875909 | risankizumab 150 mg/mL So | $66,076 | $39,646 | — | — | 8 |
| 253474-6875916 | risankizumab rzaa 180 mg/1.2 mL Inj | $66,076 | $39,646 | — | — | 8 |
| 252991-5793025 | coagulation factor VIIa 8000 mcg (8 mg) In | $63,312 | $37,987 | — | — | 8 |
| 2744797-4722342 | DEFIB LUMAX 740 HF-T 365608 | $62,625 | $37,575 | — | — | 8 |
| 252963-5788324 | Ocrelizumab 30 mg/ml Inj 10 ml | $60,953 | $36,572 | — | — | 8 |
| 2746234-6950726 | ICD INOGEN CRTD DF4 | $57,900 | $34,740 | — | — | 8 |
| 2746233-5276901 | DEFIB INOGEN CRT-D G141 | $57,844 | $34,706 | — | — | 8 |
| 253156-5985340 | Polatuzumab Vedotin 20 mg/mL Inj | $55,010 | $33,006 | — | — | 8 |
| 2736935-2815617 | STENT THORACIC 28MMX10CM | $53,907 | $32,344 | — | — | 8 |
| 2736936-2815618 | STENT THORACIC 28MMX15CM | $53,907 | $32,344 | — | — | 8 |
| 2736937-2815619 | STENT THORACIC 31MMX10CM | $53,907 | $32,344 | — | — | 8 |
| 2736938-2815620 | STENT THORACIC 31MMX15CM | $53,907 | $32,344 | — | — | 8 |
| 2736939-2815621 | STENT THORACIC 34MMX10CM | $53,907 | $32,344 | — | — | 8 |
| 2736940-2815622 | STENT THORACIC 34MMX15CM | $53,907 | $32,344 | — | — | 8 |
| 2736941-2815623 | STENT THORACIC 37MMX10CM | $53,907 | $32,344 | — | — | 8 |
| 2736942-2815624 | STENT THORACIC 37MMX15CM | $53,907 | $32,344 | — | — | 8 |
| 2736943-2815625 | STENT THORACIC 40MMX10CM | $53,907 | $32,344 | — | — | 8 |
| 2736944-2815626 | STENT THORACIC 40MMX15CM | $53,907 | $32,344 | — | — | 8 |
| 2746233-6950013 | ICD INOGEN CRTD DF1 | $53,336 | $32,002 | — | — | 8 |
| 2744797-6950802 | ICD LUMAX 740HF-T TI W/LANDLN | $52,110 | $31,266 | — | — | 8 |
| 2743629-4616121 | SPINAL CORD STIM PREC PLUS SYS | $51,293 | $30,776 | — | — | 8 |
| 2746236-5276904 | DEFIB INOGEN DR DF4 D142 | $51,188 | $30,713 | — | — | 8 |
| 253524-6915762 | Efgartigimod alfa-hyaluronidase qvfc 1008 mg Inj | $47,514 | $28,508 | — | — | 8 |
| 253387-6751596 | Nivolumab-Relatlimab rmbw 240 mg-80 mg/20 ml | $45,595 | $27,357 | — | — | 8 |
| 253598-7097464 | Tarlatamab-dlle 10 mg Inj | $44,349 | $26,609 | — | — | 8 |
| 2746238-5276906 | DEFIB INOGEN VR DF4 D140 | $44,299 | $26,579 | — | — | 8 |
| 253614-7156846 | Retifanlimab dlwr 500 mg/20 mL inj | $43,590 | $26,154 | — | — | 8 |
| 253420-6875385 | ustekinumab 45 mg/0.5 mL Inj | $43,028 | $25,817 | — | — | 9 |
| 253421-6875386 | ustekinumab 45 mg/0.5 mL Syringe | $43,028 | $25,817 | — | — | 8 |
| 253094-5878673 | CABAZItaxel 10 mg/mL Inj | $42,456 | $25,474 | — | — | 8 |
| 2746236-6950618 | ICD INOGEN EL DR DF4 | $41,246 | $24,748 | — | — | 8 |
| 253483-6887574 | Pertuzumab/Trastuzumab/Hyaluronidase 1200 mg-600 mg-30,000 units | $41,151 | $24,690 | — | — | 8 |
| 251681-4857292 | Pegaspargase 750 I-Units/ml Inj 5 ml | $39,824 | $23,894 | — | — | 8 |
| 252990-5793024 | coagulation factor VIIa 5000 mcg (5 mg) In | $39,578 | $23,747 | — | — | 8 |
| 27224842-6910927 | EXCLUDER AORT IBC 23X14X10 FA | $38,824 | $23,294 | — | — | 8 |
Showing top 50 of 20,367 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.